News
Sarclisa approved in EU as first anti-CD38 therapy in combination with standard-of-care VRd to...
Following the adoption of a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), the EU has...
Glox Therapeutics awarded share of £3m Collaborative Discovery Programme funding from Cystic Fibrosis Antimicrobial...
Glox Therapeutics, a company developing precision antibiotic therapies based on naturally occurring bacteriocins, has been awarded a share of the £3 million Collaborative Discovery...
Pioneer Group drives AI innovation in healthcare through industry and academic collaboration
Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to...
